Antibiotic-Associated Dysbiosis and Management
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: 20 February 2025 | Viewed by 1586
Special Issue Editor
Interests: dysbiosis; antibiotics; immunity; microbiota; intervention
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are currently seeking high-quality research papers, reviews, and short communications for an upcoming Special Issue entitled "Antibiotic-Associated Dysbiosis and Management." Antibiotic-associated dysbiosis refers to the imbalance of the mucosal microbiota caused by antibiotic treatments, which can lead to various adverse health outcomes. The aim of this Special Issue is to explore the complex interactions between antibiotics, dysbiosis, and immunity, as well as the application of innovative interventions to manage dysbiosis and restore the health of the microbiota. Topics of interest include, but are not limited to, the following:
- Dysbiosis: Investigations into the disruption of the microbial balance in the gut and other mucosal surfaces due to antibiotic use.
- Mucosal or systemic Immunity: Research exploring how dysbiosis affects mucosal immune responses and the overall immune system.
- Microbiota: Insights into the composition and function of microbiota communities in health and disease, particularly in the context of antibiotic exposure.
- Management or Intervention: Innovative strategies and interventions aimed at preventing or managing antibiotic-associated dysbiosis and restoring microbial balance.
Prof. Dr. Yuseok Moon
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- dysbiosis
- antibiotics
- immunity
- microbiota
- intervention
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
